glp-1 lasker Lotte Bjerre Knudsen: The Scientist Who Drove Drugs For Obesity and Alzheimer's Lasker Awards - Page 1

They cover why clinician capacity is a bottleneck, how the 40-participant pilot will measure confidence and competence, updates on efforts to restart Marylands paused schizophrenia keto trial, and how ketogenic therapy compares with GLP-1 medications for managing antipsychotic metabolic side effects

MAINTENANCE DOSE

The study indicated that a concentration of 320 g/mL of Mangifera indica used in the in vitro model suppresses DPP-4 and enhances GLP-1 for type 2 diabetes mellitus (T2DM) [32]

A 2025 database study published in the International Journal of Impotence Research found that non-diabetic obese men prescribed semaglutide for weight loss had a 4.5-fold higher risk of erectile dysfunction and nearly double the risk of testosterone deficiency compared to matched controls not taking the drug

Obesity and diabetes are well known risk factors for Alzheimers disease, and taking steps to maintain good heart and metabolic health can go a long way in helping to keep the brain in good working order

These formulations are customized to your bodys needs, not mass-produced